Depressive Disorders Market 2027 by Type, Application | The Insight Partners

Depressive Disorders Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Others); Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Long Term Care Centers)

Report Code: TIPRE00008238 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

A mental health disorder is a depressed mood or loss of interest in activities, causing significant impairment in daily life. Depression includes a variety of mental health problems characterized by the absence of positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. There are many factors, including genes, factors such as stress, and brain chemistry that could lead to depression.

MARKET DYNAMICS

The depressive disorders market is reduced efficacy and safety profiles of the drug, preference for non-pharmacological therapies, and an increase in the number of patent expiration of antidepressants lead to the weak pipeline are anticipated to hinder the market growth. However, an increase in the prevalence of depression, the rise in the geriatric population with fewer side-effects, restrains the market. Moreover, an increase in awareness regarding the disease state and required clinical needs and an increase in the number of people suffering from stress drive market growth.

MARKET SCOPE

The "Depressive Disorders Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in depressive disorders market with detailed market segmentation by type, reptile, mode of action and geography. The depressive disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in depressive disorders market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The depressive disorders market is segmented on the basis of type and application. Based on type the market is segmented as tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors and others. On the basis of application the market is categorized as hospitals, ambulatory surgical centers, diagnostic centers, homecare settings and long term care centers.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in depressive disorders market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The depressive disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting depressive disorders market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the depressive disorders market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in depressive disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in depressive disorders market are anticipated to have lucrative growth opportunities in the future with the rising demand for in depressive disorders market in the global market. Below mentioned is the list of few companies engaged in the depressive disorders market.

The report also includes the profiles of key in depressive disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Alkermes
  •  Allergan
  •  Bristol Myers Squibb
  •  Eli Lilly and Company
  •  Glaxosmithkline plc
  •  H. Lundbeck
  •  Merck & Co., Inc.
  •  Pfizer Inc
  •  Takeda Pharmaceutical Company Limited
  •  Teva Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Depressive Disorder Market - By Type
1.3.2 Depressive Disorder Market - By Application
1.3.3 Depressive Disorder Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. DEPRESSIVE DISORDER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. DEPRESSIVE DISORDER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. DEPRESSIVE DISORDER MARKET - GLOBAL MARKET ANALYSIS
6.1. DEPRESSIVE DISORDER - GLOBAL MARKET OVERVIEW
6.2. DEPRESSIVE DISORDER - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. DEPRESSIVE DISORDER MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRICYCLIC ANTIDEPRESSANTS
7.3.1. Overview
7.3.2. Tricyclic Antidepressants Market Forecast and Analysis
7.4. SELECTIVE SEROTONIN REUPTAKE INHIBITORS
7.4.1. Overview
7.4.2. Selective Serotonin Reuptake Inhibitors Market Forecast and Analysis
7.5. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
7.5.1. Overview
7.5.2. Serotonin-Norepinephrine Reuptake Inhibitors Market Forecast and Analysis
7.6. MONOAMINE OXIDASE INHIBITORS
7.6.1. Overview
7.6.2. Monoamine Oxidase Inhibitors Market Forecast and Analysis
7.7. SEROTONIN ANTAGONIST AND REUPTAKE INHIBITORS
7.7.1. Overview
7.7.2. Serotonin Antagonist And Reuptake Inhibitors Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis

8. DEPRESSIVE DISORDER MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. DIAGNOSTIC CENTERS
8.5.1. Overview
8.5.2. Diagnostic Centers Market Forecast and Analysis
8.6. HOMECARE SETTINGS
8.6.1. Overview
8.6.2. Homecare Settings Market Forecast and Analysis
8.7. LONG TERM CARE CENTERS
8.7.1. Overview
8.7.2. Long Term Care Centers Market Forecast and Analysis

9. DEPRESSIVE DISORDER MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Depressive Disorder Market Overview
9.1.2 North America Depressive Disorder Market Forecasts and Analysis
9.1.3 North America Depressive Disorder Market Forecasts and Analysis - By Type
9.1.4 North America Depressive Disorder Market Forecasts and Analysis - By Application
9.1.5 North America Depressive Disorder Market Forecasts and Analysis - By Countries
9.1.5.1 United States Depressive Disorder Market
9.1.5.1.1 United States Depressive Disorder Market by Type
9.1.5.1.2 United States Depressive Disorder Market by Application
9.1.5.2 Canada Depressive Disorder Market
9.1.5.2.1 Canada Depressive Disorder Market by Type
9.1.5.2.2 Canada Depressive Disorder Market by Application
9.1.5.3 Mexico Depressive Disorder Market
9.1.5.3.1 Mexico Depressive Disorder Market by Type
9.1.5.3.2 Mexico Depressive Disorder Market by Application
9.2. EUROPE
9.2.1 Europe Depressive Disorder Market Overview
9.2.2 Europe Depressive Disorder Market Forecasts and Analysis
9.2.3 Europe Depressive Disorder Market Forecasts and Analysis - By Type
9.2.4 Europe Depressive Disorder Market Forecasts and Analysis - By Application
9.2.5 Europe Depressive Disorder Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Depressive Disorder Market
9.2.5.1.1 Germany Depressive Disorder Market by Type
9.2.5.1.2 Germany Depressive Disorder Market by Application
9.2.5.2 France Depressive Disorder Market
9.2.5.2.1 France Depressive Disorder Market by Type
9.2.5.2.2 France Depressive Disorder Market by Application
9.2.5.3 Italy Depressive Disorder Market
9.2.5.3.1 Italy Depressive Disorder Market by Type
9.2.5.3.2 Italy Depressive Disorder Market by Application
9.2.5.4 Spain Depressive Disorder Market
9.2.5.4.1 Spain Depressive Disorder Market by Type
9.2.5.4.2 Spain Depressive Disorder Market by Application
9.2.5.5 United Kingdom Depressive Disorder Market
9.2.5.5.1 United Kingdom Depressive Disorder Market by Type
9.2.5.5.2 United Kingdom Depressive Disorder Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Depressive Disorder Market Overview
9.3.2 Asia-Pacific Depressive Disorder Market Forecasts and Analysis
9.3.3 Asia-Pacific Depressive Disorder Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Depressive Disorder Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Depressive Disorder Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Depressive Disorder Market
9.3.5.1.1 Australia Depressive Disorder Market by Type
9.3.5.1.2 Australia Depressive Disorder Market by Application
9.3.5.2 China Depressive Disorder Market
9.3.5.2.1 China Depressive Disorder Market by Type
9.3.5.2.2 China Depressive Disorder Market by Application
9.3.5.3 India Depressive Disorder Market
9.3.5.3.1 India Depressive Disorder Market by Type
9.3.5.3.2 India Depressive Disorder Market by Application
9.3.5.4 Japan Depressive Disorder Market
9.3.5.4.1 Japan Depressive Disorder Market by Type
9.3.5.4.2 Japan Depressive Disorder Market by Application
9.3.5.5 South Korea Depressive Disorder Market
9.3.5.5.1 South Korea Depressive Disorder Market by Type
9.3.5.5.2 South Korea Depressive Disorder Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Depressive Disorder Market Overview
9.4.2 Middle East and Africa Depressive Disorder Market Forecasts and Analysis
9.4.3 Middle East and Africa Depressive Disorder Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Depressive Disorder Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Depressive Disorder Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Depressive Disorder Market
9.4.5.1.1 South Africa Depressive Disorder Market by Type
9.4.5.1.2 South Africa Depressive Disorder Market by Application
9.4.5.2 Saudi Arabia Depressive Disorder Market
9.4.5.2.1 Saudi Arabia Depressive Disorder Market by Type
9.4.5.2.2 Saudi Arabia Depressive Disorder Market by Application
9.4.5.3 U.A.E Depressive Disorder Market
9.4.5.3.1 U.A.E Depressive Disorder Market by Type
9.4.5.3.2 U.A.E Depressive Disorder Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Depressive Disorder Market Overview
9.5.2 South and Central America Depressive Disorder Market Forecasts and Analysis
9.5.3 South and Central America Depressive Disorder Market Forecasts and Analysis - By Type
9.5.4 South and Central America Depressive Disorder Market Forecasts and Analysis - By Application
9.5.5 South and Central America Depressive Disorder Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Depressive Disorder Market
9.5.5.1.1 Brazil Depressive Disorder Market by Type
9.5.5.1.2 Brazil Depressive Disorder Market by Application
9.5.5.2 Argentina Depressive Disorder Market
9.5.5.2.1 Argentina Depressive Disorder Market by Type
9.5.5.2.2 Argentina Depressive Disorder Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. DEPRESSIVE DISORDER MARKET, KEY COMPANY PROFILES
11.1. ALKERMES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALLERGAN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRISTOL MYERS SQUIBB
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. H. LUNDBECK
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Alkermes
2. Allergan
3. Bristol Myers Squibb
4. Eli Lilly and Company
5. Glaxosmithkline plc
6. H. Lundbeck
7. Merck & Co., Inc.
8. Pfizer Inc
9. Takeda Pharmaceutical Company Limited
10. Teva Pharmaceutical Industries Ltd.
TIPRE00008238
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking